This is interesting, since ApoA1 is believed to be a marker of neural degeneration and increased CSF concentrations have been seen in patients with neurodegenerative disorders such as AD, Parkinson's disease and multiple sclerosis [17]. Here, APOA1 is linked to Parkinson disease.